Clinical trial
Dexmedetomidine or Clonidine Infusion for Prevention of Delirium After Open…
NCT05029050 · Oslo University Hospital, Other · Recruiting
Key facts
| NCT number | NCT05029050 |
|---|---|
| Title | Dexmedetomidine or Clonidine Infusion for Prevention of Delirium After Open Heart Surgery |
| Official title | Alpha 2 Adrenergic Receptor Agonists for the Prevention of Delirium and Cognitive Decline After Open Heart Surgery (ALPHA2PREVENT): Randomised Controlled Trial. |
| Acronym | ALPHA2PREVENT |
| Lead sponsor | Oslo University Hospital, Other |
| Collaborators | Haukeland University Hospital University Hospital of North Norway UMC Utrecht Sahlgrenska University Hospital St. Olavs Hospital |
| Status | Recruiting |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Delirium, Cognitive Decline, Frailty |
| Intervention type | Drug |
| Interventions | Dexmedetomidine, Clonidine, Natriumchlorid |
| Enrollment | 900 |
| Start date | Jan 17, 2022 |
| Primary completion | Jul 1, 2024 |
| Completion | Jan 1, 2025 |
| First posted | Aug 31, 2021 |
| Last update posted | Apr 30, 2024 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: